Galen Partners

Galen has enjoyed a long and successful track record of partnering with experienced and driven management teams to build large, sustainable businesses. Galen achieves this by leveraging healthcare experience and a network of industry relationships to help provide management partners with the necessary resources and support to create and implement impressive growth plans.

Since 1990, they have built an investment portfolio with an aggregate market value of over $10 billion–and helped 70 of their portfolio companies navigate through the complicated paths of public offerings, debt financings, and mergers and acquisitions. As such, over the past decade they have gained recognition as one of the largest and most influential names in healthcare private equity investing.

Galen Partners, established in 1990 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Software, Hardware, Fitness, Information Technology, Consumer, Health Care, mHealth, Financial Services, Venture Capital, Finance. The organization boasts a portfolio of 27 investments, with an average round size of $15.9M and 13 successful exits. Their recent investments include Dakim, Sharecare, TomorrowVentures, Quotient Biodiagnostics, Tactile Medical. The highest investment round they participated in was $20.8B. Among their most notable exits are Dakim and Sharecare. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.